
Yosef Manla, MD, FESC
@manlayosef
Incoming IM PGY-1 | Postdoc-Scientist @SmidtHeart-@CedarsSinai | Former Research Scholar @ Cleveland Clinic @CCAD| FESC @escardio |
ID: 1392820725732544515
https://scholar.google.com/citations?user=vu3oRckAAAAJ&hl=en&oi=ao 13-05-2021 12:35:21
166 Tweet
256 Takipçi
326 Takip Edilen

Presenting our findings on predictors of Ischemia reperfusion injury post heart transplant #AHA24 Smidt Heart Institute at Cedars-Sinai Cedars-Sinai Academic Medicine We found that: Optimal prioritization of HTx candidates on the waitlist and use of ATG induction therapy seem to protect against immediate ischemia
